CS logo
small CS logo
Irccs Ospedale San Raffaele;Oncologia Medica

Milano, Lombardia, Italy

About Irccs Ospedale San Raffaele;Oncologia Medica


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Irccs Ospedale San Raffaele;Oncologia Medica


During the past decade, Irccs Ospedale San Raffaele;Oncologia Medica conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 11 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Irccs Ospedale San Raffaele;Oncologia Medica" #1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "Jazz Pharmaceuticals" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Irccs Ospedale San Raffaele;Oncologia Medica


According to Clinical.Site data, the most researched conditions in "Irccs Ospedale San Raffaele;Oncologia Medica" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Advanced Solid Tumors" (1 trials) and "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Irccs Ospedale San Raffaele;Oncologia Medica" in a lesser frequency.

Clinical Trials Intervention Types at Irccs Ospedale San Raffaele;Oncologia Medica


Most popular intervention types in "Irccs Ospedale San Raffaele;Oncologia Medica" are "Drug" (19 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (7 trials), "Bevacizumab" (5 trials), "Docetaxel" (5 trials), "Carboplatin" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Irccs Ospedale San Raffaele;Oncologia Medica


The vast majority of trials in "Irccs Ospedale San Raffaele;Oncologia Medica" are 18 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Irccs Ospedale San Raffaele;Oncologia Medica


Currently, there are NaN active trials in "Irccs Ospedale San Raffaele;Oncologia Medica". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Irccs Ospedale San Raffaele;Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Irccs Ospedale San Raffaele;Oncologia Medica, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".